```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[S. 3031 Introduced in Senate (IS)]

111th CONGRESS
  2d Session
                                S. 3031

To authorize Drug Free Communities enhancement grants to address major 
               emerging drug issues or local drug crises.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 24, 2010

Mr. Leahy (for himself and Mr. Grassley) introduced the following bill; 
  which was read twice and referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
To authorize Drug Free Communities enhancement grants to address major 
               emerging drug issues or local drug crises.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Drug Free Communities Enhancement 
Act of 2010''.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) The epidemiology of drug use indicates that emerging 
        drug trends increase over a short period of time and tend to 
        cluster in discrete geographic areas. Historical evidence shows 
        that emerging local drug issues and crises can be stopped or 
        mitigated before they spread to other areas, if they are 
        identified quickly and addressed in a comprehensive multi-
        sector manner.
            (2) Federal investments in drug prevention should not be 
        solely based on national data and trends, but must be flexible 
        enough to address emerging local problems and local drug crises 
        before they become national trends.
            (3) Successful drug prevention must be based on local data 
        and involve multiple community sectors in planning and 
        implementing specifically targeted strategies that respond to 
        the unique drug problems of the community.
            (4) Data and outcomes show that effective community 
        coalitions can markedly reduce local drug use rates for drugs 
        such as marijuana and inhalants among school-aged youth.
            (5) Community coalitions are singularly situated to deal 
        with emerging drug issues and local drug crises, such as 
        methamphetamine, cheese (a mixture of black tar heroin and 
        Tylenol PM), and prescription and non-prescription drug abuse 
        because the community coalitions are organized, data driven, 
        and take a comprehensive, multi-sector approach to solving and 
        addressing locally identified drug problems.
            (6) Providing enhancement grants to coalitions to address 
        emerging local drug issues or local drug crises is a cost 
        effective way to deal with these drug issues. This approach 
        builds on existing infrastructures with proven results that 
        include all of the relevant community sectors needed to 
        comprehensively address specific emerging drug issues and 
        crises, and guards against using Federal funding to create 
        duplicative community based infrastructures for substance abuse 
        prevention.

SEC. 3. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO ADDRESS 
              EMERGING DRUG ISSUES OR LOCAL DRUG CRISES.

    (a) Definitions.--In this section--
            (1) the term ``Director'' means the Director of the Office 
        of National Drug Control Policy;
            (2) the term ``drug'' means--
                    (A) a substance listed on schedule I, II, III, IV, 
                or V of section 202 of the Controlled Substances Act 
                (21 U.S.C. 812(c));
                    (B) inhalants;
                    (C) if used in a manner that is illegal, a 
                prescription or over the counter drug or medicine; and
                    (D) another mind altering substance with the 
                potential for abuse, as determined by the Director, not 
                listed on a schedule of section 202(c) of the 
                Controlled Substance Act (21 U.S.C. 812(c));
            (3) the term ``emerging local drug issue'' means, with 
        respect to the area served by an eligible entity, a sudden 
        increase in the use or abuse of a particular drug in the 
        community, as documented by local data;
            (4) the term ``local drug crisis'' means, with respect to 
        the area served by an eligible entity, the use of a specific 
        drug in the area at levels that are significantly higher than 
        the national average, over a sustained period of time, as 
        documented by local data; and
            (5) the term ``eligible entity'' means an organization 
        that--
                    (A) is receiving or has received a grant under 
                chapter 2 of title I of the National Narcotics 
                Leadership Act of 1988 (21 U.S.C. 1521 et seq.) 
                (commonly known as the Drug-Free Communities Act of 
                1997); and
                    (B) has documented, using local data--
                            (i) for an emerging local drug issue--
                                    (I) rates of drug use and abuse 
                                above the national average, as 
                                determined by the Director (including 
                                appropriate consideration of the 
                                Monitoring of the Future Survey 
                                published by the Department of Health 
                                and Human Services), for comparable 
                                time periods; or
                                    (II) if national data is not 
                                available, at the discretion of the 
                                Director, high rates of drug use or 
                                abuse based solely on valid local data; 
                                or
                            (ii) for a local drug crisis--
                                    (I) rates of use and abuse for a 
                                specific drug at levels that are 
                                significantly higher than the national 
                                average, as determined by the Director 
                                (including appropriate consideration of 
                                the Monitoring of the Future Survey 
                                published by the Department of Health 
                                and Human Services and the National 
                                Survey on Drug Use and Health by the 
                                Substance Abuse and Mental Health 
                                Service Administration); and
                                    (II) rates of use and abuse for a 
                                specific drug that continue over a 
                                sustained period of time, as determined 
                                by the Director.
    (b) Authorization of Program.--The Director may make enhancement 
grants to eligible entities to implement comprehensive community-wide 
strategies that address emerging local drug issues or local drug crises 
within the area served by the eligible entity.
    (c) Application.--
            (1) In general.--An eligible entity desiring an enhancement 
        grant under this section shall submit an application to the 
        Director at such time, in such manner, and accompanied by such 
        information as the Director may require.
            (2) Criteria.--As part of an application for a grant under 
        this section, the Director shall require an eligible entity to 
        submit a detailed, comprehensive, multi-sector plan for 
        addressing the emerging local drug issue or local drug crises 
        within the area served by the eligible entity.
    (d) Uses of Funds.--A grant under this section shall be used to--
            (1) implement comprehensive, community-wide prevention 
        strategies to address an emerging local drug issue or drug 
        crises in the area served by an eligible entity, in accordance 
        with the plan submitted under subsection (c)(2); and
            (2) obtain specialized training and technical assistance 
        from the entity receiving a grant under section 4 of Public Law 
        107-82 (21 U.S.C. 1521 note).
    (e) Grant Amounts.--
            (1) In general.--The total amount of grant funds awarded to 
        an eligible entity for a fiscal year may not exceed the amount 
        of non-Federal funds raised by the eligible entity, including 
        in-kind contributions, for that fiscal year.
            (2) Grant awards.--A grant under this section shall--
                    (A) be made for a period of not more than 4 years; 
                and
                    (B) be for not more than $75,000 per year.
    (f) Supplement Not Supplant.--Grant funds provided under this 
section shall be used to supplement, not supplant, Federal and non-
Federal funds available for carrying out the activities described in 
this section.
    (g) Evaluation.--A grant under this section shall be subject to the 
same evaluation requirements and procedures as the evaluation 
requirements and procedures imposed on the recipient of a grant under 
chapter 2 of title I of the National Narcotics Leadership Act of 1988 
(21 U.S.C. 1521 et seq.) (commonly known as the Drug-Free Communities 
Act of 1997).
    (h) Administrative Expenses.--Not more than 5 percent of the amount 
appropriated to carry out this section for any fiscal year may be used 
by the Director for administrative expenses.
    (i) Authorization of Appropriations.--There are authorized to be 
appropriated $5,000,000 for each of fiscal years 2011 through 2015 to 
carry out this section.
                                 <all>
```